NASDAQ
02.07.25 | 15:30
6,160 US-Dollar
+0,98 % +0,060
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.06. | Profound Medical Corp (2): Profound completes first BPH treatment with Tulsa-Pro | 1 | Stockwatch | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 10.06. | Profound Medical Corp.: Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction | 1 | GlobeNewswire (USA) | ||
| 04.06. | Profound Medical Corp (2): Profound Medical names ex-NFLer Wheeler as ambassador | 2 | Stockwatch | ||
| 04.06. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.06. | Profound Medical Corp.: Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO | 1 | GlobeNewswire (USA) | ||
| 15.05. | Profound Medical Corp (2): Profound Medical shareholders approve AGM resolutions | 1 | Stockwatch | ||
| 14.05. | Profound Medical Corp.: Profound Medical Annual General and Special Meeting of Shareholders Voting Results | 77 | GlobeNewswire (Europe) | TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General and Special... ► Artikel lesen | |
| 09.05. | Profound Medical stock rating downgraded at Raymond James | 1 | Investing.com | ||
| 09.05. | Profound Medical GAAP EPS of $0.36, revenue of $2.6M | 2 | Seeking Alpha | ||
| 09.05. | Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch | 1 | Seeking Alpha | ||
| 09.05. | Profound Medical Corp. Bottom Line Rises In Q1 | - | RTTNews | ||
| 08.05. | Profound Medical Corp. Q1 Loss Increases, Misses Estimates | - | RTTNews | ||
| 08.05. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 08.05. | Profound Medical Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.04. | Is Profound Medical a buy right now? | 1 | Cantech Letter | ||
| 29.04. | Profound Medical Corp (2): Profound releases perioperative data from Captain trial | 1 | Stockwatch | ||
| 29.04. | Stocks in Play: Profound Medical Corp. | 2 | Baystreet.ca | ||
| 29.04. | Profound Medical Corp.: Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy | 1 | GlobeNewswire (USA) | ||
| 22.04. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.04. | Profound Medical Corp (2): Profound Medical to release Q1 results May 8 | 2 | Stockwatch |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 58,18 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,750 | -1,18 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 22,010 | 0,00 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
| ALIGNMENT HEALTHCARE | 13,610 | -4,22 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 55,00 | -2,83 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
| FRESENIUS | 42,410 | +0,31 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,340 | -0,17 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen auf "Buy" mit einem Kursziel von 60 Euro belassen. Julien Dormois fasste in einer am Donnerstag... ► Artikel lesen | |
| MIMEDX | 6,230 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results | Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA... ► Artikel lesen | |
| NUTEX HEALTH | 122,29 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| GENEDX | 89,79 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
| ONCOLOGY INSTITUTE | 2,440 | 0,00 % | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | ||
| 908 DEVICES | 6,605 | 0,00 % | 908 Devices Inc.: Romanian Customs Authority Adopts 908 Devices' MX908 for Border Security Operations | The handheld mass spectrometers are now in active use for trace detection and identification of drugs and explosives for customs and border patrol applications 908 Devices Inc. (Nasdaq: MASS)... ► Artikel lesen | |
| GOODRX | 5,055 | +1,92 % | GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies | ||
| PROGYNY | 21,240 | -3,72 % | Progyny, Inc.: Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women's health and family building, today announced the appointments of Melissa Cummings as the company's first... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,920 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,98 % bei einem Aktienkurs von 6,160 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.